Spengler, Ulrich

Publishing since 1983 (Dinosaur)

Has published 233 publications in 28 years

Number of publications published per year by Spengler, Ulrich. (Source : PubMed)

Distribution of publications types for Spengler, Ulrich. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Langhans B, Braunschweiger I, Arndt S, Schulte W, Satoguina J, Layland LE, Vidovic N, Hoerauf A, Oldenburg J, Sauerbruch T, Spengler U. Core-specific adaptive regulatory T cells in different outcomes of hepatitis C.  Clinical science (London, England : 1979)  2010  
•  Sarrazin C, Berg T, Ross RS, Schirmacher P, Wedemeyer H, Neumann U, Schmidt HH, Spengler U, Wirth S, Kessler HH, Peck-Radosavljevic M, Ferenci P, Vogel W, Moradpour D, Heim M, Cornberg M, Protzer U, Manns MP, Fleig WE, Dollinger MM, Zeuzem S. [Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]  Z Gastroenterol  2010;48;2  
•  Grünhage F, Nattermann J, Gressner OA, Wasmuth HE, Hellerbrand C, Sauerbruch T, Spengler U, Lammert F. Lower copy numbers of the chemokine CCL3L1 gene in patients with chronic hepatitis C.  J. Hepatol.  2010;52;2  
•  van Bömmel F, de Man RA, Wedemeyer H, Deterding K, Petersen J, Buggisch P, Erhardt A, Hüppe D, Stein K, Trojan J, Sarrazin C, Böcher WO, Spengler U, Wasmuth HE, Reinders JG, Möller B, Rhode P, Feucht HH, Wiedenmann B, Berg T. Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues.  Hepatology  2010;51;1  
•  Terjung B, Soehne J, Lechtenberg B, Gottwein J, Muennich M, Herzog V, Maehler M, Sauerbruch T, Spengler U. p-ANCA in Autoimmune Liver Disorders Recognize Human Beta-Tubulin Isotype 5 and Cross-react with Microbial Protein FtsZ.  Gut  2009  
•  Krämer B, Schulte D, Körner C, Zwank C, Hartmann A, Michalk M, Söhne J, Langhans B, Nischalke HD, Coenen M, Möhl C, Vogt A, Hennenberg M, Sauerbruch T, Spengler U, Nattermann J. Regulation of NK cell trafficking by CD81.  Eur. J. Immunol.  2009;39;12  
•  Schulte D, Vogel M, Langhans B, Krämer B, Körner C, Nischalke HD, Steinberg V, Michalk M, Berg T, Rockstroh JK, Sauerbruch T, Spengler U, Nattermann J. The HLA-E(R)/HLA-E(R) genotype affects the natural course of hepatitis C virus (HCV) infection and is associated with HLA-E-restricted recognition of an HCV-derived peptide by interferon-gamma-secreting human CD8(+) T cells.  J. Infect. Dis.  2009;200;9  
•  Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, Bassendine M, Spengler U, Dore GJ, Powell E, Riordan S, Sheridan D, Smedile A, Fragomeli V, Müller T, Bahlo M, Stewart GJ, Booth DR, George J. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.  Nat. Genet.  2009;41;10  
•  Berg T, Weich V, Teuber G, Klinker H, Möller B, Rasenack J, Hinrichsen H, Gerlach T, Spengler U, Buggisch P, Balk H, Zankel M, Neumann K, Sarrazin C, Zeuzem S. Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients.  Hepatology  2009;50;2  
•  Leifeld L, Clemens C, Heller J, Trebicka J, Sauerbruch T, Spengler U. Expression of Urotensin II and Its Receptor in Human Liver Cirrhosis and Fulminant Hepatic Failure.  Dig. Dis. Sci.  2009  

[ See timeline ] [ See all publications ]